1. Home
  2. GVH vs PRFX Comparison

GVH vs PRFX Comparison

Compare GVH & PRFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Globavend Holdings Limited

GVH

Globavend Holdings Limited

N/A

Current Price

$0.92

Market Cap

2.6M

Sector

N/A

ML Signal

N/A

Logo PainReform Ltd.

PRFX

PainReform Ltd.

N/A

Current Price

$0.73

Market Cap

3.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GVH
PRFX
Founded
2016
2007
Country
Australia
Israel
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6M
3.1M
IPO Year
2023
2020

Fundamental Metrics

Financial Performance
Metric
GVH
PRFX
Price
$0.92
$0.73
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
24.8K
★ 27.1K
Earning Date
07-14-2026
09-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$1.85
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$0.74
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.77
$0.58
52 Week High
$6.46
$5.39

Technical Indicators

Market Signals
Indicator
GVH
PRFX
Relative Strength Index (RSI) 43.57 36.68
Support Level $0.87 $0.69
Resistance Level $1.13 $1.28
Average True Range (ATR) 0.07 0.05
MACD 0.00 0.00
Stochastic Oscillator 46.95 22.15

Price Performance

Historical Comparison
GVH
PRFX

About GVH Globavend Holdings Limited

Globavend Holdings Ltd is an e-commerce logistics provider, it provides integrated cross-border logistics services from Hong Kong to Australia and New Zealand, where it provides customers with a one-stop solution from parcel consolidation to air freight forwarding, customs clearance, on-carriage parcel transportation and delivery. It operates in logistics and freight forwarding industry, which involves the provision of services such as freight transport, freight forwarding, warehouse management, and distribution.

About PRFX PainReform Ltd.

PRF Technologies Ltd is a a diversified platform spanning speciality pharmaceuticals, drug-delivery technologies, and AI-driven renewable-energy analytics. PRF Technologies focuses on pharmaceutical therapies that emphasize reformulation and sustained-release drug-delivery technologies and AI-driven energy analytics. PRF-110, the company's lead product, is based on the local anesthetic ropivacaine and targets the postoperative pain relief market. The company has two operating segments composed of the Clinical Development segment, which facilitates the development of potential new drug compounds, and the Solar segment, which comprises the design and development of the company's intellectual property and the sale related service offerings.

Share on Social Networks: